FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to compounds of general formula and their pharmaceutically acceptable salts, which possess activity of antagonist of muscarinic receptors. In formula (I) R1 is selected from the group, consisting of aryl, heteroaryl and aryl-(C1-C6)-alkyl, optionally substituted with one or more substituents, selected from the group, consisting of halogen atoms, CON(R5)2, COR5, CO2R5, (C1-C6)-alkyl and (C1-C6)-alkoxyl; R2 stands for H or (C1-C6)-alkyl; R3 is selected from the group, consisting of phenyl, pyridyl and benzothiophenyl, optionally substituted with one or more substituents, selected from the group, consisting of OH, (C1-C6)-alkoxyl and aryl-(C1-C6)-alkoxyl; R5 is selected independently from H and (C1-C6)-alkyl; Q stands for the group of formula or ; R4 stands for the group of formula , where p stands for 0 or integer number from 1 to 4; q stands for 0 or integer number from 1 to 4; P is absent or is selected from the group, consisting of O, CO and C(O)N(R5); W is selected from the group, consisting of H, (C1-C6)-alkyl, (C2-C6)-alkenyl, aryl and heteroaryl, optionally substituted with one or more substituents, selected from the group, consisting of halogen atoms and OH; A- stands for physiologically acceptable anion, with at least one of R1 and R3 standing for heteroaryl group and when Q represents the group of formula (i) and R3 represents phenyl, R1 is different from 2-(methoxycarbonyl)thiophen-3-yl.
EFFECT: invention relates to pharmaceutical compositions, including formula (I) compound, to device, including said pharmaceutical composition, as well as to thereof application in treatment of bronchial obstructive and inflammatory diseases.
17 cl, 50 ex
Title | Year | Author | Number |
---|---|---|---|
GLYCINE DERIVATIVES AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS | 2011 |
|
RU2585767C2 |
DERIVATIVES OF ALKALOID AMINOESTER AND THEIR DRUG COMPOSITIONS | 2011 |
|
RU2567548C2 |
HINUCLIDINE ETHERS OF 1-AZAHETEROCYLIC ACETIC ACID AS ANTIMUSCARINE MEANS, METHOD FOR THEIR PRODUCTION AND THEIR DRUG COMPOSITIONS | 2012 |
|
RU2628082C2 |
ALKALOID DERIVATIVES BASED ON AMINOESTERS AND COMPOSITIONS OF MEDICATIONS CONTAINING THEM | 2011 |
|
RU2580835C2 |
ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | 2012 |
|
RU2611627C2 |
DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS INHIBITORS | 2012 |
|
RU2617401C2 |
FUSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679914C9 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
NMDA RECEPTOR MODULATORS AND THEIR APPLICATION | 2012 |
|
RU2621049C2 |
HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USING SAID INHIBITORS | 2007 |
|
RU2447065C2 |
Authors
Dates
2015-11-27—Published
2011-05-30—Filed